CL2016002413A1 - Anticuerpos de hemaglutinina contra el virus de la influenza b y métodos de uso - Google Patents
Anticuerpos de hemaglutinina contra el virus de la influenza b y métodos de usoInfo
- Publication number
- CL2016002413A1 CL2016002413A1 CL2016002413A CL2016002413A CL2016002413A1 CL 2016002413 A1 CL2016002413 A1 CL 2016002413A1 CL 2016002413 A CL2016002413 A CL 2016002413A CL 2016002413 A CL2016002413 A CL 2016002413A CL 2016002413 A1 CL2016002413 A1 CL 2016002413A1
- Authority
- CL
- Chile
- Prior art keywords
- virus
- methods
- antibodies against
- against influenza
- hemagglutinin antibodies
- Prior art date
Links
- 101710154606 Hemagglutinin Proteins 0.000 title 1
- 241000713196 Influenza B virus Species 0.000 title 1
- 101710093908 Outer capsid protein VP4 Proteins 0.000 title 1
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 title 1
- 101710176177 Protein A56 Proteins 0.000 title 1
- 239000000185 hemagglutinin Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1018—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39583—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials not provided for elsewhere, e.g. haptens, coenzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/51—Complete heavy chain or Fd fragment, i.e. VH + CH1
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/515—Complete light chain, i.e. VL + CL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Emergency Medicine (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461971123P | 2014-03-27 | 2014-03-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2016002413A1 true CL2016002413A1 (es) | 2017-06-23 |
Family
ID=52829396
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2016002413A CL2016002413A1 (es) | 2014-03-27 | 2016-09-26 | Anticuerpos de hemaglutinina contra el virus de la influenza b y métodos de uso |
| CL2018002874A CL2018002874A1 (es) | 2014-03-27 | 2018-10-09 | Anticuerpos de hemaglutinina contra el virus de la influenza b y métodos de uso (divisional de solicitud n° 2413-2016). |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2018002874A CL2018002874A1 (es) | 2014-03-27 | 2018-10-09 | Anticuerpos de hemaglutinina contra el virus de la influenza b y métodos de uso (divisional de solicitud n° 2413-2016). |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US9745365B2 (es) |
| EP (1) | EP3122771A1 (es) |
| JP (1) | JP2017512471A (es) |
| KR (1) | KR20160135830A (es) |
| CN (1) | CN106132987A (es) |
| AR (1) | AR099855A1 (es) |
| AU (1) | AU2015235983A1 (es) |
| BR (1) | BR112016022113A2 (es) |
| CA (1) | CA2942820A1 (es) |
| CL (2) | CL2016002413A1 (es) |
| CR (1) | CR20160502A (es) |
| EA (1) | EA201691945A1 (es) |
| IL (1) | IL247870A0 (es) |
| MA (1) | MA39803A (es) |
| MX (1) | MX2016012530A (es) |
| PE (1) | PE20161376A1 (es) |
| PH (1) | PH12016501873A1 (es) |
| SG (1) | SG11201607945UA (es) |
| TW (1) | TW201620932A (es) |
| WO (1) | WO2015148806A1 (es) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7181091B2 (ja) | 2016-05-10 | 2022-11-30 | ジェネンテック， インコーポレイテッド | ポリペプチドの組み換え産生中にトリスルフィド結合を減少させる方法 |
| US20210002669A1 (en) | 2017-12-22 | 2021-01-07 | Genentech, Inc. | Targeted integration of nucleic acids |
| MA51681A (fr) | 2018-01-26 | 2021-05-05 | Regeneron Pharma | Anticorps humains contre l'hémagglutinine de la grippe |
| AR115318A1 (es) | 2018-03-29 | 2020-12-23 | Genentech Inc | Modulación de la actividad lactogénica en células de mamífero |
| CN113631711A (zh) | 2018-12-21 | 2021-11-09 | 豪夫迈·罗氏有限公司 | 核酸的靶向整合 |
| RU2714246C1 (ru) * | 2018-12-28 | 2020-02-13 | Федеральное государственное бюджетное учреждение "Научно-исследовательский институт гриппа имени А.А. Смородинцева" Министерства здравоохранения Российской Федерации | Моноклональные антитела, специфичные к различным штаммам вируса гриппа в |
| US11773156B2 (en) | 2019-10-28 | 2023-10-03 | Regeneron Pharmaceuticals, Inc. | Anti-hemagglutinin antibodies and methods of use thereof |
| MX2022008901A (es) * | 2020-01-24 | 2022-08-16 | Regeneron Pharma | Conjugados de proteinas-compuestos antivirales. |
| KR20220159426A (ko) | 2020-03-26 | 2022-12-02 | 제넨테크, 인크. | 감소된 숙주 세포 단백질을 보유하는 변형된 포유동물 세포 |
| EP4172346A1 (en) | 2020-06-24 | 2023-05-03 | Genentech, Inc. | Targeted integration of nucleic acids |
| US20220041672A1 (en) | 2020-06-24 | 2022-02-10 | Genentech, Inc. | Apoptosis resistant cell lines |
| EP4204558A2 (en) | 2020-08-28 | 2023-07-05 | Genentech, Inc. | Crispr/cas9 multiplex knockout of host cell proteins |
| CN114316032B (zh) * | 2020-09-27 | 2022-12-27 | 东莞市朋志生物科技有限公司 | 抗乙型流感病毒的抗体、检测乙型流感病毒的试剂和试剂盒 |
| JP2024514222A (ja) | 2021-04-19 | 2024-03-28 | ジェネンテック， インコーポレイテッド | 改変された哺乳動物細胞 |
| KR20240010469A (ko) | 2021-05-21 | 2024-01-23 | 제넨테크, 인크. | 관심 재조합 생성물의 생성을 위한 변형된 세포 |
| WO2024104947A2 (en) | 2022-11-14 | 2024-05-23 | Janssen Vaccines & Prevention B.V. | Influenza b virus vaccines and uses thereof |
| WO2024107879A1 (en) | 2022-11-15 | 2024-05-23 | Genentech, Inc. | Combined transposon-mediated integration and targeted integration of nucleic acids into host cells |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2921928B1 (fr) | 2007-10-08 | 2011-03-04 | Sanofi Pasteur | Anticorps monoclonaux specifiques de l'hemagglutinine du virus grippal |
| BE1018561A3 (fr) | 2008-12-24 | 2011-03-01 | Galactic Sa | Procede de purification de l'acide lactique par cristallisation. |
| US8975378B2 (en) | 2008-12-25 | 2015-03-10 | Osaka University | Human anti-human influenza virus antibody |
| DK2731967T3 (en) * | 2011-07-14 | 2017-01-16 | Janssen Vaccines & Prevention Bv | HUMAN BINDING MOLECULES CAPABLE OF NEUTRALIZING INFLUENZA A VIRUS FROM PHYLOGENETIC GROUP 1 AND PHYLOGENETIC GROUP 2 AND INFLUENZA B VIRUS |
| WO2013114885A1 (en) | 2012-01-31 | 2013-08-08 | Osaka University | Human monoclonal antibodies broadly protective against influenza b virus and methods of using the same |
| ES2664625T3 (es) * | 2012-03-08 | 2018-04-20 | Janssen Vaccines & Prevention B.V. | Moléculas de unión humanas que pueden unirse a los virus de la influenza b y neutralizarlos, y sus usos |
-
2015
- 2015-03-26 SG SG11201607945UA patent/SG11201607945UA/en unknown
- 2015-03-26 AU AU2015235983A patent/AU2015235983A1/en not_active Abandoned
- 2015-03-26 AR ARP150100900A patent/AR099855A1/es unknown
- 2015-03-26 PE PE2016001760A patent/PE20161376A1/es unknown
- 2015-03-26 TW TW104109843A patent/TW201620932A/zh unknown
- 2015-03-26 CN CN201580016217.4A patent/CN106132987A/zh active Pending
- 2015-03-26 WO PCT/US2015/022758 patent/WO2015148806A1/en active Application Filing
- 2015-03-26 EP EP15716285.0A patent/EP3122771A1/en not_active Withdrawn
- 2015-03-26 KR KR1020167029658A patent/KR20160135830A/ko unknown
- 2015-03-26 EA EA201691945A patent/EA201691945A1/ru unknown
- 2015-03-26 JP JP2016559331A patent/JP2017512471A/ja active Pending
- 2015-03-26 CA CA2942820A patent/CA2942820A1/en not_active Abandoned
- 2015-03-26 MX MX2016012530A patent/MX2016012530A/es unknown
- 2015-03-26 US US14/669,317 patent/US9745365B2/en not_active Expired - Fee Related
- 2015-03-26 CR CR20160502A patent/CR20160502A/es unknown
- 2015-03-26 BR BR112016022113A patent/BR112016022113A2/pt not_active IP Right Cessation
- 2015-03-26 MA MA039803A patent/MA39803A/fr unknown
-
2016
- 2016-09-18 IL IL247870A patent/IL247870A0/en unknown
- 2016-09-22 PH PH12016501873A patent/PH12016501873A1/en unknown
- 2016-09-26 CL CL2016002413A patent/CL2016002413A1/es unknown
-
2017
- 2017-07-24 US US15/657,433 patent/US20170320937A1/en not_active Abandoned
-
2018
- 2018-10-09 CL CL2018002874A patent/CL2018002874A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20150274812A1 (en) | 2015-10-01 |
| EP3122771A1 (en) | 2017-02-01 |
| US9745365B2 (en) | 2017-08-29 |
| CA2942820A1 (en) | 2015-10-01 |
| MA39803A (fr) | 2017-02-01 |
| US20170320937A1 (en) | 2017-11-09 |
| AR099855A1 (es) | 2016-08-24 |
| BR112016022113A2 (pt) | 2017-10-31 |
| CR20160502A (es) | 2017-02-03 |
| PE20161376A1 (es) | 2016-12-26 |
| JP2017512471A (ja) | 2017-05-25 |
| MX2016012530A (es) | 2017-01-05 |
| PH12016501873A1 (en) | 2017-01-09 |
| WO2015148806A1 (en) | 2015-10-01 |
| EA201691945A1 (ru) | 2017-02-28 |
| AU2015235983A1 (en) | 2016-10-06 |
| CL2018002874A1 (es) | 2018-12-14 |
| CN106132987A (zh) | 2016-11-16 |
| TW201620932A (zh) | 2016-06-16 |
| SG11201607945UA (en) | 2016-10-28 |
| KR20160135830A (ko) | 2016-11-28 |
| IL247870A0 (en) | 2016-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2016002413A1 (es) | Anticuerpos de hemaglutinina contra el virus de la influenza b y métodos de uso | |
| MA46766A (fr) | Vaccin antigrippal | |
| ZA201700165B (en) | Influenza virus vaccines and uses thereof | |
| IL252659B (en) | Human antibodies to influenza hemagglutinin | |
| BR112016030968A2 (pt) | análogos de pridopidina, preparação e uso destes | |
| CL2016002462A1 (es) | Anticuerpos anti-ox40 y métodos de uso | |
| BR112016015706A2 (pt) | composto, uso do mesmo e composição farmacêutica | |
| CL2018000708A1 (es) | Fitasas modificadas y métodos de uso | |
| HK1254668A1 (zh) | 流感病毒複製抑制劑及其使用方法和用途 | |
| EP3463447A4 (en) | INFLUENZA VIRUSES | |
| CL2017000063A1 (es) | Vacunas contra virus influenza y usos de las mismas | |
| DK3191489T3 (da) | Pyrrolopyrimidiner til anvendelse ved influenzavirusinfektion | |
| ES2969440T3 (es) | Anticuerpos anti-C5 y métodos de uso | |
| EP3247389A4 (en) | INFLUENZAVIRUSSCHUTZIMPFPLÄNE | |
| EP3471767A4 (en) | INFLUENZA VIRUS HEMAGGLUTININS AND USES THEREOF | |
| BR112016020889A2 (pt) | variantes de hppd e métodos de uso | |
| CL2018001139A1 (es) | Anticuerpos anti-htra1 y métodos de uso de los mismos. | |
| BR112016006614A2 (pt) | composições de trichoderma e métodos de uso | |
| FI20145086A (fi) | Parannettu rengasgyroskooppirakenne ja gyroskooppi | |
| BR112016026470A2 (pt) | Composto modulador de hsp70, composição farmacêutica que o compreende e uso do referido composto | |
| SG11201704942QA (en) | Dengue virus vaccine compositions and methods of use thereof | |
| FR3026387B1 (fr) | Carenage de rotor, rotor et aeronef | |
| EP3157950A4 (en) | Influenza vaccines and methods of use thereof | |
| IL249704A0 (en) | Influenza virus vaccines and their uses | |
| IL249705A0 (en) | Influenza virus vaccines and their uses |